CSIMarket
 


Akers Biosciences Inc   (AKER)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Akers Biosciences Inc 's Leverage Ratio for Trailing Twelve Months Period

AKER's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth



AKER Leverage Ratio for Trailing Twelve Months Period

(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Equity Growth 37.28 % 60.36 % -53.39 % -60.04 % -56.51 %
Y / Y Total Liabilities Growth 10.98 % -22.48 % -40.34 % -12.65 % 50.52 %
Leverage Ratio for Trailing Twelve Months Period 0.28 0.3 0.38 0.35 0.28
Total Ranking # 492 # 598 # 722 # 710 # 469
Seq. Equity Growth -27.13 % 160 % -16.6 % -13.13 % -14.88 %
Seq. Total Liabilities Growth 50.63 % 11.42 % -15.13 % -22.09 % 5.22 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite net new borrowings of 50.63% Akers Biosciences Inc managed to decrease Leverage Ratio for Trailing Twelve Months Period in I. Quarter to 0.28, below Akers Biosciences Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Drugs industry 58 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Akers Biosciences Inc . While Leverage Ratio for Trailing Twelve Months Period total ranking has improved so far to 492, from total ranking in previous quarter at 598.

What is Leverage Ratio?
Who are AKER's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 59
Sector # 198
S&P 500 # 490


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.38 0.28 0.12
(Sep 30 2019)   (Dec. 30, 2015)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2020, within Biotechnology & Drugs Industry Leverage Ratio for Trailing Twelve Months Period
Spark Therapeutics Inc   0.77 
Acasti Pharma Inc   0.75 
Protagonist Therapeutics Inc   0.74 
Surface Oncology Inc   0.73 
Eiger Biopharmaceuticals Inc   0.73 
Syndax Pharmaceuticals Inc  0.70 
Quidel Corp  0.70 
Black Diamond Therapeutics Inc   0.69 
Windtree Therapeutics Inc  0.69 
Immunovant Inc   0.68 
Unum Therapeutics Inc   0.63 
Vermillion Inc   0.63 
Precipio Inc   0.63 
Cidara Therapeutics Inc   0.61 
Nymox Pharmaceutical Corporation  0.59 
Meridian Bioscience Inc  0.59 
Eloxx Pharmaceuticals Inc   0.59 
Foamix Pharmaceuticals Ltd   0.58 
Cv Sciences Inc   0.58 
Allena Pharmaceuticals Inc   0.57 
Medicure Inc  0.57 
Bio techne Corp  0.56 
Pluristem Therapeutics Inc  0.56 
Jounce Therapeutics Inc   0.55 
Voyager Therapeutics Inc   0.54 
Atyr Pharma Inc  0.54 
Cellular Biomedicine Group Inc   0.53 
Volitionrx Ltd  0.52 
Sangamo Therapeutics Inc   0.52 
Cue Biopharma Inc   0.51 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ALX's Profile

Stock Price

ALX's Financials

Business Description

Fundamentals

Charts & Quotes

ALX's News

Suppliers

ALX's Competitors

Customers & Markets

Economic Indicators

ALX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071